Search Results - Michael Untch

Refine Results
  1. 1

    Systematic literature review and trial-level meta-analysis of aromatase inhibitors vs tamoxifen in patients with HR+/HER2− early breast cancer by Wolfgang Janni, Michael Untch, Nadia Harbeck, Joseph Gligorov, William Jacot, Stephen Chia, Jean-François Boileau, Subhajit Gupta, Namita Mishra, Murat Akdere, Andriy Danyliv, Giuseppe Curigliano

    Published in Breast (2025-06-01)
    Get full text
    Article


  2. 2

    Prevalence and prognosis of patients with breast cancer eligible for adjuvant abemaciclib or ribociclib: a nationwide population-based studyResearch in context by Xingrong Liu, Behnaz Binicy, Balazs Acs, Louise Eriksson Bergman, Sibylle Loibl, Michael Gnant, Michael Untch, Antonios Valachis, Jonas Bergh, Johan Hartman, Theodoros Foukakis, Alexios Matikas

    Published in The Lancet Regional Health. Europe (2025-12-01)
    Get full text
    Article


  3. 3

    Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trialResearch in context by Alexios Matikas, Andri Papakonstantinou, Sibylle Loibl, Günther G. Steger, Michael Untch, Hemming Johansson, Nikos Tsiknakis, Mats Hellström, Richard Greil, Volker Möbus, Michael Gnant, Jonas Bergh, Theodoros Foukakis

    Published in The Lancet Regional Health. Europe (2025-02-01)
    Get full text
    Article


  4. 4

    Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemot... by David Krug, Valentina Vladimirova, Michael Untch, Thorsten Kühn, Andreas Schneeweiss, Carsten Denkert, Beyhan Ataseven, Christine Solbach, Bernd Gerber, Hans Tesch, Michael Golatta, Sabine Seiler, Jörg Heil, Valentina Nekljudova, Johannes Holtschmidt, Sibylle Loibl

    Published in Breast (2024-04-01)
    Get full text
    Article


  5. 5

    On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer by Bruno Valentin Sinn, Katharina Sychra, Michael Untch, Thomas Karn, Marion van Mackelenbergh, Jens Huober, Wolfgang Schmitt, Frederik Marmé, Christian Schem, Christine Solbach, Elmar Stickeler, Hans Tesch, Peter A. Fasching, Andreas Schneeweiss, Volkmar Müller, Johannes Holtschmidt, Valentina Nekljudova, Sibylle Loibl, Carsten Denkert

    Published in Breast Cancer Research (2024-09-01)
    Get full text
    Article


  6. 6

    Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy by Jens Huober, Marion van Mackelenbergh, Andreas Schneeweiss, Fenja Seither, Jens-Uwe Blohmer, Carsten Denkert, Hans Tesch, Claus Hanusch, Christoph Salat, Kerstin Rhiem, Christine Solbach, Peter A. Fasching, Christian Jackisch, Mattea Reinisch, Bianca Lederer, Keyur Mehta, Theresa Link, Valentina Nekljudova, Sibylle Loibl, Michael Untch

    Published in npj Breast Cancer (2023-04-01)
    Get full text
    Article


  7. 7

    Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE by Sibylle Loibl, Chiun-Sheng Huang, Max S. Mano, Eleftherios P. Mamounas, Charles E. Geyer, Michael Untch, Jean-Christophe Thery, Ingo Schwaner, Steven Limentani, Niklas Loman, Kristina Lübbe, Jenny C. Chang, Thomas Hatschek, David Tesarowski, Chunyan Song, Sanne Lysbet de Haas, Thomas Boulet, Chiara Lambertini, Norman Wolmark

    Published in npj Breast Cancer (2022-09-01)
    Get full text
    Article


  8. 8

    Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers by Lothar Häberle, Ramona Erber, Paul Gass, Alexander Hein, Melitta Niklos, Bernhard Volz, Carolin C. Hack, Rüdiger Schulz-Wendtland, Hanna Huebner, Chloë Goossens, Matthias Christgen, Thilo Dörk, Tjoung-Won Park-Simon, Andreas Schneeweiss, Michael Untch, Valentina Nekljudova, Sibylle Loibl, Arndt Hartmann, Matthias W. Beckmann, Peter A. Fasching

    Published in Breast Cancer Research (2025-01-01)
    Get full text
    Article


  9. 9

    Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC by Thomas Karn, Frederik Marmé, Christian Jackisch, Barbara Seliger, Chiara Massa, Sibylle Loibl, Volkmar Müller, Carsten Denkert, Andreas Schneeweiss, Claus Hanusch, Jens-Uwe Blohmer, Dirk-Michael Zahm, Marion van Mackelenbergh, Jörg Thomalla, Jens Huober, Christian Schem, Anja Mueller, Elmar Stickeler, Katharina Biehl, Peter A Fasching, Michael Untch, Karsten Weber

    Published in Journal for ImmunoTherapy of Cancer (2020-10-01)
    Get full text
    Article


  10. 10

    Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple‐negative breast cancer patients by Chiara Massa, Thomas Karn, Karsten Weber, Andreas Schneeweiss, Claus Hanusch, Jens Uwe Blohmer, Dirk‐Michael Zahm, Christian Jackisch, Marion van Mackelenbergh, Jörg Thomalla, Frederik Marmé, Jens Huober, Volkmar Müller, Christian Schem, Anja Müller, Elmar Stickeler, Katharina Biehl, Peter A. Fasching, Michael Untch, Sibylle Loibl, Carsten Denkert, Barbara Seliger

    Published in Clinical and Translational Medicine (2024-04-01)
    Get full text
    Article


  11. 11

    Prospective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto... by Yasmin Issa-Nummer, Silvia Darb-Esfahani, Sibylle Loibl, Georg Kunz, Valentina Nekljudova, Iris Schrader, Bruno Valentin Sinn, Hans-Ullrich Ulmer, Ralf Kronenwett, Marianne Just, Thorsten Kühn, Kurt Diebold, Michael Untch, Frank Holms, Jens-Uwe Blohmer, Jörg-Olaf Habeck, Manfred Dietel, Friedrich Overkamp, Petra Krabisch, Gunter von Minckwitz, Carsten Denkert

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  12. 12

    Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference - Su... by Mattea Reinisch, Michael Untch, Rolf Mahlberg, Toralf Reimer, Thomas Hitschold, Frederik Marmé, Mustafa Aydogdu, Sabine Schmatloch, Hans-Joachim Lück, Marcus Schmidt, Ekkehart Ladda, Bruno Valentin Sinn, Peter Klare, Wolfgang Janni, Christian Jackisch, Carsten Denkert, Sabine Seiler, Thomas Göhler, Laura Michel, Nicole Burchardi, Elmar Stickeler, Julia Rey, Nicole Klutinus, Volker Möbus, Sibylle Loibl

    Published in Breast (2022-12-01)
    Get full text
    Article


  13. 13

    Macrophage polarization is associated with postoperative seroma development in breast cancer in the SerMa pilot cohort by Felicitas Magdalena Schneider, Nicole Pochert, Fritzi Schittek, Melitta Beatrice Köpke, Carl Mathis Wild, Johanna Marie Veh, Natalie Renate Rohrmoser, Christina Kuhn, Birgit Urban, Klaus-Henning Kahl, Mariella Schneider, Angelika Mattmer, Ludwig Christian Hinske, Regina Fluhrer, Monika M. Golas, Michael Untch, Thorsten Kuehn, Maggie Banys-Paluchowski, Udo Jeschke, Claudia Traidl-Hoffmann, Christian Dannecker, Nina Ditsch

    Published in Scientific Reports (2025-09-01)
    Get full text
    Article


  14. 14

    Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer by Marion T. Van Mackelenbergh, Nicole Pfarr, Karsten Weber, Michael Untch, Christine Solbach, Andreas Schneeweiss, Paul Jank, Jens Blohmer, Denise Treue, Sabine Schmatloch, Annika Lehmann, Claus Hanusch, Theresa Link, Christine Sers, Vesna Bjelic-Radisic, Michael Hummel, Jens Huober, Wolfgang D. Schmitt, Peter A. Fasching, Bahriye Aktas, Kerstin Rhiem, Mattea Reinisch, Valentina Nekljudova, Carsten Denkert, Sibylle Loibl

    Published in npj Breast Cancer (2026-04-01)
    Get full text
    Article


  15. 15

    GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer by Volker Möbus, Hans-Joachim Lück, Ekkehart Ladda, Peter Klare, Knut Engels, Marcus Schmidt, Andreas Schneeweiss, Eva-Maria Grischke, Grischa Wachsmann, Helmut Forstbauer, Michael Untch, Frederik Marmé, Jens-Uwe Blohmer, Christian Jackisch, Jens Huober, Elmar Stickeler, Mattea Reinisch, Theresa Link, Bruno Sinn, Wolfgang Janni, Carsten Denkert, Sabine Seiler, Christine Solbach, Sabine Schmatloch, Julia Rey, Sibylle Loibl

    Published in npj Breast Cancer (2024-07-01)
    Get full text
    Article


  16. 16

    Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial by Katya Galactionova, Sibylle Loibl, Paola Salari, Frederik Marmé, Miguel Martin, Miguel Martin, Michael Untch, Hervé R. Bonnefoi, Sung-Bae Kim, Harry D. Bear, Nicole McCarthy, Nicole McCarthy, Karen A. Gelmon, José A. García-Sáenz, José A. García-Sáenz, Catherine M. Kelly, Toralf Reimer, Masakazu Toi, Hope S. Rugo, Michael Gnant, Andreas Makris, Nicole Burchardi, Matthias Schwenkglenks

    Published in Frontiers in Oncology (2022-09-01)
    Get full text
    Article


  17. 17

    Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness by Otto Metzger-Filho, Katharine Collier, Sarah Asad, Peter J. Ansell, Mark Watson, Junu Bae, Mathew Cherian, Joyce O’Shaughnessy, Michael Untch, Hope S. Rugo, Jens B. Huober, Mehra Golshan, William M. Sikov, Gunter von Minckwitz, Priya Rastogi, Lang Li, Lijun Cheng, David Maag, Norman Wolmark, Carsten Denkert, W. Fraser Symmans, Charles E. Geyer, Sibylle Loibl, Daniel G. Stover

    Published in npj Breast Cancer (2021-11-01)
    Get full text
    Article


  18. 18

    Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany by Hanna Huebner, Christian M. Kurbacher, Geoffrey Kuesters, Andreas D. Hartkopf, Michael P. Lux, Jens Huober, Bernhard Volz, Florin-Andrei Taran, Friedrich Overkamp, Hans Tesch, Lothar Häberle, Diana Lüftner, Markus Wallwiener, Volkmar Müller, Matthias W. Beckmann, Erik Belleville, Matthias Ruebner, Michael Untch, Peter A. Fasching, Wolfgang Janni, Tanja N. Fehm, Hans-Christian Kolberg, Diethelm Wallwiener, Sara Y. Brucker, Andreas Schneeweiss, Johannes Ettl

    Published in BMC Cancer (2020-11-01)
    Get full text
    Article


  19. 19

    Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy endocrine therapy alone in patients with HR+/HER2− early breast cancer by Dennis J. Slamon, Peter A. Fasching, Sara Hurvitz, Stephen Chia, John Crown, Miguel Martín, Carlos H. Barrios, Aditya Bardia, Seock-Ah Im, Denise A. Yardley, Michael Untch, Chiun-Sheng Huang, Daniil Stroyakovskiy, Binghe Xu, Rebecca L. Moroose, Sherene Loi, Frances Visco, Valerie Bee-Munteanu, Karen Afenjar, Rodrigo Fresco, Tetiana Taran, Arunava Chakravartty, Juan Pablo Zarate, Agnes Lteif, Gabriel N. Hortobagyi

    Published in Therapeutic Advances in Medical Oncology (2023-05-01)
    Get full text
    Article


  20. 20

    The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype by Philipp Ziegler, Andreas D. Hartkopf, Markus Wallwiener, Lothar Häberle, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Johannes Ettl, Diana Lüftner, Volkmar Müller, Laura L. Michel, Erik Belleville, Pauline Wimberger, Carsten Hielscher, Hanna Huebner, Sabrina Uhrig, Lena A. Wurmthaler, Carolin C. Hack, Christoph Mundhenke, Christian Kurbacher, Peter A. Fasching, Rachel Wuerstlein, Michael Untch, Wolfgang Janni, Florin-Andrei Taran, Michael P. Lux, Diethelm Wallwiener, Sara Y. Brucker, Tanja N. Fehm, Andreas Schneeweiss, Chloë Goossens

    Published in BMC Cancer (2024-10-01)
    Get full text
    Article


Search Tools: